171 related articles for article (PubMed ID: 28730484)
21. Oncogenic Mutations Rewire Signaling Pathways by Switching Protein Recruitment to Phosphotyrosine Sites.
Lundby A; Franciosa G; Emdal KB; Refsgaard JC; Gnosa SP; Bekker-Jensen DB; Secher A; Maurya SR; Paul I; Mendez BL; Kelstrup CD; Francavilla C; Kveiborg M; Montoya G; Jensen LJ; Olsen JV
Cell; 2019 Oct; 179(2):543-560.e26. PubMed ID: 31585087
[TBL] [Abstract][Full Text] [Related]
22. Quantitative proteomic approaches for studying phosphotyrosine signaling.
Ding SJ; Qian WJ; Smith RD
Expert Rev Proteomics; 2007 Feb; 4(1):13-23. PubMed ID: 17288512
[TBL] [Abstract][Full Text] [Related]
23. Absolute Phosphorylation Stoichiometry Analysis by Motif-Targeting Quantitative Mass Spectrometry.
Tsai CF; Ku WC; Chen YJ; Ishihama Y
Methods Mol Biol; 2017; 1636():313-325. PubMed ID: 28730488
[TBL] [Abstract][Full Text] [Related]
24. Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling.
Humphrey ES; Su SP; Nagrial AM; Hochgräfe F; Pajic M; Lehrbach GM; Parton RG; Yap AS; Horvath LG; Chang DK; Biankin AV; Wu J; Daly RJ
Mol Cell Proteomics; 2016 Aug; 15(8):2671-85. PubMed ID: 27259358
[TBL] [Abstract][Full Text] [Related]
25. Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways.
Wu X; Zahari MS; Ma B; Liu R; Renuse S; Sahasrabuddhe NA; Chen L; Chaerkady R; Kim MS; Zhong J; Jelinek C; Barbhuiya MA; Leal-Rojas P; Yang Y; Kashyap MK; Marimuthu A; Ling M; Fackler MJ; Merino V; Zhang Z; Zahnow CA; Gabrielson E; Stearns V; Roa JC; Sukumar S; Gill PS; Pandey A
Oncotarget; 2015 Oct; 6(30):29143-60. PubMed ID: 26356563
[TBL] [Abstract][Full Text] [Related]
26. A Tyrosine Phosphoproteome Analysis Approach Enabled by Selective Dephosphorylation with Protein Tyrosine Phosphatase.
Liu X; Dong M; Yao Y; Wang Y; Mao J; Hu L; Yao L; Ye M
Anal Chem; 2022 Mar; 94(10):4155-4164. PubMed ID: 35239328
[TBL] [Abstract][Full Text] [Related]
27. Tandem Mass Tag Approach Utilizing Pervanadate BOOST Channels Delivers Deeper Quantitative Characterization of the Tyrosine Phosphoproteome.
Chua XY; Mensah T; Aballo T; Mackintosh SG; Edmondson RD; Salomon AR
Mol Cell Proteomics; 2020 Apr; 19(4):730-743. PubMed ID: 32071147
[TBL] [Abstract][Full Text] [Related]
28. Phosphoproteomics Analysis Identifies Novel Candidate Substrates of the Nonreceptor Tyrosine Kinase,
Goel RK; Paczkowska M; Reimand J; Napper S; Lukong KE
Mol Cell Proteomics; 2018 May; 17(5):925-947. PubMed ID: 29496907
[TBL] [Abstract][Full Text] [Related]
29. Targeted quantitative phosphoproteomics approach for the detection of phospho-tyrosine signaling in plants.
Mithoe SC; Boersema PJ; Berke L; Snel B; Heck AJ; Menke FL
J Proteome Res; 2012 Jan; 11(1):438-48. PubMed ID: 22074104
[TBL] [Abstract][Full Text] [Related]
30. Identification of tyrosine phosphoproteins in signaling pathway triggered TGF-a by using functional proteomics technology.
Ruan L; Wang GL; Chen Y; Yi H; Tang CE; Zhang PF; Li MY; Li C; Peng F; Li JL; Chen ZC; Xiao ZQ
Med Oncol; 2010 Dec; 27(4):1407-14. PubMed ID: 20049563
[TBL] [Abstract][Full Text] [Related]
31. Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine Proteomics.
Haake SM; Li J; Bai Y; Kinose F; Fang B; Welsh EA; Zent R; Dhillon J; Pow-Sang JM; Chen YA; Koomen JM; Rathmell WK; Fishman M; Haura EB
Clin Cancer Res; 2016 Nov; 22(22):5605-5616. PubMed ID: 27220961
[TBL] [Abstract][Full Text] [Related]
32. Integration of proteomic analyses to monitor the activity status of phosphorylation signaling.
Nagano K; Shinkawa T; Yabuki N; Mutoh H; Inomata N; Watanabe Y; Ashihara M; Nagahashi S; Ishii N; Aoki Y; Haramura M
J Proteomics; 2011 Mar; 74(3):319-26. PubMed ID: 21118733
[TBL] [Abstract][Full Text] [Related]
33. Mass spectrometry analysis of phosphotyrosine-containing proteins.
Li J; Zhan X
Mass Spectrom Rev; 2024; 43(4):857-887. PubMed ID: 36789499
[TBL] [Abstract][Full Text] [Related]
34. Automated Enrichment of Phosphotyrosine Peptides for High-Throughput Proteomics.
Chang A; Leutert M; Rodriguez-Mias RA; Villén J
J Proteome Res; 2023 Jun; 22(6):1868-1880. PubMed ID: 37097255
[TBL] [Abstract][Full Text] [Related]
35. Quantitative analysis of HGF and EGF-dependent phosphotyrosine signaling networks.
Hammond DE; Hyde R; Kratchmarova I; Beynon RJ; Blagoev B; Clague MJ
J Proteome Res; 2010 May; 9(5):2734-42. PubMed ID: 20222723
[TBL] [Abstract][Full Text] [Related]
36. Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome, and tyrosine-phosphatome in acute myeloid leukemia.
Tong J; Helmy M; Cavalli FM; Jin L; St-Germain J; Karisch R; Taylor P; Minden MD; Taylor MD; Neel BG; Bader GD; Moran MF
Proteomics; 2017 Mar; 17(6):. PubMed ID: 28176486
[TBL] [Abstract][Full Text] [Related]
37. Purification and identification of tyrosine-phosphorylated proteins from B lymphocytes stimulated through the antigen receptor.
Gold MR; Yungwirth T; Sutherland CL; Ingham RJ; Vianzon D; Chiu R; van Oostveen I; Morrison HD; Aebersold R
Electrophoresis; 1994; 15(3-4):441-53. PubMed ID: 7519980
[TBL] [Abstract][Full Text] [Related]
38. Tyrosine phosphorylation mapping of the epidermal growth factor receptor signaling pathway.
Steen H; Kuster B; Fernandez M; Pandey A; Mann M
J Biol Chem; 2002 Jan; 277(2):1031-9. PubMed ID: 11687594
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the Phospho-Adhesome by Mass Spectrometry-Based Proteomics.
Robertson J; Humphries JD; Paul NR; Warwood S; Knight D; Byron A; Humphries MJ
Methods Mol Biol; 2017; 1636():235-251. PubMed ID: 28730483
[TBL] [Abstract][Full Text] [Related]
40. Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells.
Thelemann A; Petti F; Griffin G; Iwata K; Hunt T; Settinari T; Fenyo D; Gibson N; Haley JD
Mol Cell Proteomics; 2005 Apr; 4(4):356-76. PubMed ID: 15657067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
